Montréal enSanté V8N2 Printemps/Spring 2016 | Page 71

PHOTO: LOIC PRAVAZ g  reproductible d’un centre à l’autre et per- gg  New criteria for Parkinson’s diagnosis non spécialisés dans la maladie de Parkin- University Health Centre (MGH-MUHC), the rate of misdiagnosis for PD can be as high mettre à un plus grand éventail de cliniciens son à fournir un diagnostic exact à leurs patients. » Par exemple, les patients atteints du parkinson perdent souvent l’odorat, un symptôme plus rare en présence d’autres maladies. Ce symptôme fait désormais partie According to Dr. Ron Postuma, neurologist at the Montreal General Hospital of the McGill as 25 per cent. “Full diagnostic certainty is impossible during life because it closely resembles other neurological disorders,’’ explains Dr. Postuma, who has been working for 15 years on Parkinson’s. “On top of creating distress in patients, mistaken diagnosis also creates a challenge for researchers as the data collected in clinical studies can become compromised in their pool of subjects.’’ Currently, diagnosis of Parkinson’s can only be established through an analysis of des critères pour aider les médecins à poser medical history and a neurological examination by a clinician with expertise in move- mettent de concilier l’information au moyen by an international group of experts, under the umbrella of the International Parkinson le diagnostic. Les nouveaux critères perde caractéristiques négatives, les «  signaux d’alarme », qui plaident contre un diagnostic de parkinson, et de caractéristiques positives, ment disorders – no objective test for the disease exists. However, a recent research led and Movement Disorder Society (MDS), may pave the way for improving diagnosis and advancing treatment of Parkinson’s. “In light of the latest scientific insights and technological advances, we were able qui plaident pour un tel diagnostic. Pour écar- to establish a new list of criteria based on expert clinical diagnosis,” says Dr. Postuma, signaux d’alarme doivent être contrebalan- logical Hospital/Institute, who was co-chair of the MDS task force with Dr. Daniela Berg ter un diagnostic probable de parkinson, les cés par des critères positifs. Des recherches axées sur un diagnostic rapide clinical-scientist from the Research Institute of the MUHC and from The Montreal Neuro- from Tubingen, Germany. “Our aim was to create a benchmark that will systematize the diagnostic process, make it reproducible across centres and enable a wider range of non PD-specialized clinicians to provide patients with an accurate diagnosis.” For example, the sense of smell is commonly lost in PD patients but uncommonly lost L’équipe de recherche a poussé son analyse in alternate diseases. Now, it is included in the diagnostic criteria as another way to help la maladie par stades, afin de se concentrer cluding negative features called ‘red flags’ that argue against a diagnosis of PD and posi- plus loin. Elle propose une classification de sur les premiers stades de la maladie de Parkinson avant même que les patients g physicians make the diagnosis. The new criteria has ways to balance information by intive features that argue for a PD diagnosis. Red flags rule out probable PD diagnosis only when they cannot be counterbalanced by supportive criteria. gg SPRING2016 2016 MONTRÉAL enSANTÉ SPRING 69